Dr. Miele Cosmed Group (DMG) Stock Overview
Engages in the production and sale of chemical and cosmetic assortments in Poland and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
DMG Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Dr. Miele Cosmed Group S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł2.26 |
| 52 Week High | zł3.94 |
| 52 Week Low | zł2.11 |
| Beta | 0.22 |
| 1 Month Change | 0.89% |
| 3 Month Change | -15.04% |
| 1 Year Change | -40.99% |
| 3 Year Change | 7.62% |
| 5 Year Change | -44.34% |
| Change since IPO | 22.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| DMG | PL Personal Products | PL Market | |
|---|---|---|---|
| 7D | -0.4% | 1.8% | 2.2% |
| 1Y | -41.0% | -29.4% | 32.2% |
Return vs Industry: DMG underperformed the Polish Personal Products industry which returned -29.4% over the past year.
Return vs Market: DMG underperformed the Polish Market which returned 32.2% over the past year.
Price Volatility
| DMG volatility | |
|---|---|
| DMG Average Weekly Movement | 6.0% |
| Personal Products Industry Average Movement | 5.1% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in PL Market | 11.0% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: DMG has not had significant price volatility in the past 3 months compared to the Polish market.
Volatility Over Time: DMG's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 542 | Magdalena Miele | dr-miele.eu |
Dr. Miele Cosmed Group S.A. engages in the production and sale of chemical and cosmetic assortments in Poland and internationally. The company offers washing and care cosmetics, wet wipes, and laundry detergents for children; cleansing cosmetics, such as sanitizing gels and sprays, and liquid soaps; shower gels; and toilet cleaners, toilet blocks, and drain opener granules and gels; washing liquids and fabric softening concentrates; cleaning agents for kitchens and bathrooms; and hand sanitizing and surface disinfectants. The company markets its products primarily under the Bobini, Apart, Biophen, Mole, Sofin, Izo, and Izozid brands.
Dr. Miele Cosmed Group S.A. Fundamentals Summary
| DMG fundamental statistics | |
|---|---|
| Market cap | zł197.39m |
| Earnings (TTM) | zł16.23m |
| Revenue (TTM) | zł499.56m |
Is DMG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DMG income statement (TTM) | |
|---|---|
| Revenue | zł499.56m |
| Cost of Revenue | zł326.22m |
| Gross Profit | zł173.33m |
| Other Expenses | zł157.10m |
| Earnings | zł16.23m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Sep 17, 2026
| Earnings per share (EPS) | 0.19 |
| Gross Margin | 34.70% |
| Net Profit Margin | 3.25% |
| Debt/Equity Ratio | 18.7% |
How did DMG perform over the long term?
See historical performance and comparisonDividends
Does DMG pay a reliable dividends?
See DMG dividend history and benchmarks| Dr. Miele Cosmed Group dividend dates | |
|---|---|
| Ex Dividend Date | Jul 01 2026 |
| Dividend Pay Date | Aug 20 2026 |
| Days until Ex dividend | 16 days |
| Days until Dividend pay date | 66 days |
Does DMG pay a reliable dividends?
See DMG dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/15 10:06 |
| End of Day Share Price | 2026/06/12 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dr. Miele Cosmed Group S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.